Drugs / PB127
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00487903 | Sep 2007 → Mar 2008 | coronary artery disorder | Point Biomedical | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT00584818 | Nov 2006 → Mar 2008 | coronary artery disorder | Point Biomedical | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00594698 | Feb 2002 → Sep 2003 | coronary artery disorder | Point Biomedical | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT00584896 | Oct 2007 → Jul 2008 | coronary artery disorder | Point Biomedical | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT00595244 | Jul 2002 → Oct 2003 | coronary artery disorder | Point Biomedical | Completed | No outcome recorded |
| Phase 3 | NCT00595673 | Jul 2002 → Oct 2003 | coronary artery disorder | Point Biomedical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PB127 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00584818 ↗ |
| Modality | Diagnostic / imaging agent | “Ultrasound Contrast Agent” NCT00584818 ↗ |
| Route | Intravenous | “continuous IV” NCT00487903 ↗ |